291 related articles for article (PubMed ID: 25847765)
1. Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents.
Liu S; Wei W; Li Y; Liu X; Cao X; Lei K; Zhou M
Eur J Med Chem; 2015 May; 95():473-82. PubMed ID: 25847765
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, molecular docking studies and anti-HBV activity of phenylpropanoid derivatives.
Liu S; Li Y; Wei W; Wang K; Wang L; Wang J
Chem Biol Interact; 2016 May; 251():1-9. PubMed ID: 26980103
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, structure-activity relationships and biological evaluation of caudatin derivatives as novel anti-hepatitis B virus agents.
Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Guo RH; Zhang XM; Chen JJ
Bioorg Med Chem; 2012 May; 20(9):2877-88. PubMed ID: 22472044
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents.
Guo RH; Zhang Q; Ma YB; Luo J; Geng CA; Wang LJ; Zhang XM; Zhou J; Jiang ZY; Chen JJ
Eur J Med Chem; 2011 Jan; 46(1):307-19. PubMed ID: 21145140
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Bioactive Screen In Vitro of Cyclohexyl (
Cui X; Zhou M; Tan J; Wei Z; Wei W; Luo P; Lin C
Molecules; 2019 May; 24(11):. PubMed ID: 31151219
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Oxime Ethers as Hepatitis B Virus (HBV) Inhibitors by Docking, Screening and In Vitro Investigation.
Tan J; Zhou M; Cui X; Wei Z; Wei W
Molecules; 2018 Mar; 23(3):. PubMed ID: 29534537
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, structure-activity relationships and biological evaluation of dehydroandrographolide and andrographolide derivatives as novel anti-hepatitis B virus agents.
Chen H; Ma YB; Huang XY; Geng CA; Zhao Y; Wang LJ; Guo RH; Liang WJ; Zhang XM; Chen JJ
Bioorg Med Chem Lett; 2014 May; 24(10):2353-9. PubMed ID: 24731274
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents.
Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Zhang XM; Chen JJ
Bioorg Med Chem Lett; 2012 May; 22(10):3473-9. PubMed ID: 22520261
[TBL] [Abstract][Full Text] [Related]
9. Anti-hepatitis B virus active constituents from Swertia chirayita.
Zhou NJ; Geng CA; Huang XY; Ma YB; Zhang XM; Wang JL; Chen JJ
Fitoterapia; 2015 Jan; 100():27-34. PubMed ID: 25447162
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of caudatin analogs as potent hepatitis B virus inhibitors.
Wang LJ; Chen H; Ma YB; Huang XY; Geng CA; Zhang XM; Chen JJ
Med Chem; 2015; 11(2):165-79. PubMed ID: 25181984
[TBL] [Abstract][Full Text] [Related]
11. Anti-HBV agents. Part 2: synthesis and in vitro anti-hepatitis B virus activities of alisol A derivatives.
Zhang Q; Jiang ZY; Luo J; Liu JF; Ma YB; Guo RH; Zhang XM; Zhou J; Chen JJ
Bioorg Med Chem Lett; 2009 Apr; 19(8):2148-53. PubMed ID: 19289281
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of erythrocentaurin derivatives as a new class of hepatitis B virus inhibitors.
Geng CA; Huang XY; Ma YB; Zhang XM; Chen JJ
Bioorg Med Chem Lett; 2015 Apr; 25(7):1568-71. PubMed ID: 25737009
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological assay of 4-aryl-6-chloro-quinoline derivatives as novel non-nucleoside anti-HBV agents.
Guo RH; Zhang Q; Ma YB; Huang XY; Luo J; Wang LJ; Geng CA; Zhang XM; Zhou J; Jiang ZY; Chen JJ
Bioorg Med Chem; 2011 Feb; 19(4):1400-8. PubMed ID: 21292495
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of celastrol derivatives as potential non-nucleoside hepatitis B virus inhibitors.
Zhang H; Lu G
Chem Biol Drug Des; 2020 Dec; 96(6):1380-1386. PubMed ID: 32573976
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of hemslecin A derivatives: a new class of hepatitis B virus inhibitors.
Guo RH; Geng CA; Huang XY; Ma YB; Zhang Q; Wang LJ; Zhang XM; Zhang RP; Chen JJ
Bioorg Med Chem Lett; 2013 Mar; 23(5):1201-5. PubMed ID: 23385212
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and evaluation of pyrazole derivatives as non-nucleoside hepatitis B virus inhibitors.
Jia H; Bai F; Liu N; Liang X; Zhan P; Ma C; Jiang X; Liu X
Eur J Med Chem; 2016 Nov; 123():202-210. PubMed ID: 27484509
[TBL] [Abstract][Full Text] [Related]
17. Anti-HBV agents. Part 1: Synthesis of alisol A derivatives: a new class of hepatitis B virus inhibitors.
Zhang Q; Jiang ZY; Luo J; Cheng P; Ma YB; Zhang XM; Zhang FX; Zhou J; Chen JJ
Bioorg Med Chem Lett; 2008 Aug; 18(16):4647-50. PubMed ID: 18644720
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of new N(4)-Substituted 2'-deoxy-2'-fluoro-4'-azido cytidine derivatives as potent anti-HBV agents.
Lv Z; He W; Tian X; Kang J; Liu Y; Peng Y; Zheng L; Wang Q; Yu W; Chang J
Eur J Med Chem; 2015 Aug; 101():103-10. PubMed ID: 26119991
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-hepatitis B virus activity of C4 amide-substituted isosteviol derivatives.
Huang TJ; Yang CL; Kuo YC; Chang YC; Yang LM; Chou BH; Lin SJ
Bioorg Med Chem; 2015 Feb; 23(4):720-8. PubMed ID: 25600408
[TBL] [Abstract][Full Text] [Related]
20. Bioactivity-guided isolation of anti-hepatitis B virus active sesquiterpenoids from the traditional Chinese medicine: Rhizomes of Cyperus rotundus.
Xu HB; Ma YB; Huang XY; Geng CA; Wang H; Zhao Y; Yang TH; Chen XL; Yang CY; Zhang XM; Chen JJ
J Ethnopharmacol; 2015 Aug; 171():131-40. PubMed ID: 26051832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
